peptide antibiotic antineoplasticOncology Peptides

Actinomycin D (Dactinomycin)

A peptide antibiotic from Streptomyces parvullus. FDA-approved anticancer agent for Wilms tumor, rhabdomyosarcoma, Ewing sarcoma, and gestational trophoblastic neoplasia. Intercalates DNA and inhibits RNA polymerase.

anticancerDNA-intercalatorpediatric-cancerFDA-approved
3D Structure
3D Structure
1255.42 Da
Molecular Weight1,255.42 Da
FormulaC62H86N12O16
PubChem CID457193
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
Intensity62879195311151278m/z1255.6
ESI-MS (computed)
Batch Info
Latest Batch
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity data
Lab Reports
0 reports on file
Summary

A peptide antibiotic from Streptomyces parvullus. FDA-approved anticancer agent for Wilms tumor, rhabdomyosarcoma, Ewing sarcoma, and gestational trophoblastic neoplasia. Intercalates DNA and inhibits…